Dr. Soliman completed an undergraduate degree in chemistry and biology at Houston Baptist University, a medical degree from the University of Texas Health Science Center, and a Ph.D in pharmacology from Florida A&M University. Prior to joining Palm Beach Atlantic University as an assistant professor of pharmaceutical sciences, Dr. Soliman taught abroad in the Middle East as an assistant professor of pharmacology at Ajman University of Science and Technology in the U.A.E., where he taught basic pharmacology and toxicology to undergraduate and graduate pharmacy students. Prior to his international work experience, he worked as an assistant professor of pharmacology at Central University of the Caribbean Medical School in Puerto Rico. His research involves identifying neuroprotective therapy for Parkinson's disease (PD). He specifically plans to investigate the ability of the combined use of ethyl pyruvate (EP) and Piroxicam to halt and/or restore the neurodegeneration in Paraquat (PQ) and maneb (MB) induced PD using C57BL/6 mice. This work is a natural extension of his previous work in which he has shown that administering Piroxicam and EP to mice was found to be neuroprotective against MPTP-induced dopaminergic degeneration in the (SNc), and loss of locomotive function. He is also currently investigating cembranoids (4R) derived from tobacco leaves that possess alpha-7 nAch receptor antagonistic properties against preclinical animal model of PD. Dr. Soliman believes in treating his students with respect, not just as students but as future health professionals & colleagues, and that a teacher should use his position and the love and respect of his students to teach them not just the scientific material but also Christian morals and ethics.